ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 ANS Annual Conference
May 31–June 3, 2026
Denver, CO|Sheraton Denver
Latest Magazine Issues
Mar 2026
Jan 2026
Latest Journal Issues
Nuclear Science and Engineering
April 2026
Nuclear Technology
February 2026
Fusion Science and Technology
Latest News
TerraPower announces second Ac-225 production facility
TerraPower Isotopes, a TerraPower subsidiary, plans to increase its actinium-225 production 20-fold by opening a new manufacturing facility in Philadelphia, Pa., and by expanding the capacity of its Everett, Wash., facility. On March 17, TerraPower Isotopes said it expects the new facility to begin producing the medical radioisotope for targeted alpha therapy in 2029.
Technical Session|Panel|Sponsored by OPD
Monday, June 13, 2022|1:00–2:45PM PDT|San Simeon A
Session Chair:
John H. Jackson
Alternate Chair:
Piyush Sabharwall
Session Organizer:
This panel will provide a brief overview on the cross-cutting research and development (R&D) that is being carried out at various national laboratories to enable technology demonstrations and successful deployment. The main objective of the R&D is to reduce uncertainty and risk in the design and development of microreactors to facilitate rapid technology commercialization. The work is broadly applicable to multiple reactor cooling/technology options to ensure that concepts can be licensed and deployed to meet specific use-case requirements.
INL
Bob Reid
Los Alamos National Laborator
Donna Guillen
Chase Taylor
Abdellatif Yacout
ANL
David Shropshire
To join the conversation, you must be logged in and registered for the meeting.
Register NowLog In